TY - JOUR
T1 - In vitro evaluation, biodistribution and scintigraphic imaging in mice of radiolabeled anthrax toxins
AU - Dadachova, Ekaterina
AU - Rivera, Johanna
AU - Revskaya, Ekaterina
AU - Nakouzi, Antonio
AU - Cahill, Sean M.
AU - Blumenstein, Michael
AU - Xiao, Hui
AU - Rykunov, Dmitry
AU - Casadevall, Arturo
N1 - Funding Information:
The research was funded by National Institutes of Health (NIH) grants 5U54AI057158-03 (AC) and AI60507 (ED). E. Revskaya was supported by NIH Postdoctoral Immunooncology and Immunology Training Award. We thank Dr. V. Pazo (Jacobi Medical Center, Bronx, NY, USA) for help with the biodistribution.
PY - 2008/10
Y1 - 2008/10
N2 - Introduction: There is a lot of interest towards creating therapies and vaccines for Bacillus anthracis, a bacterium which causes anthrax in humans and which spores can be made into potent biological weapons. Systemic injection of lethal factor (LF), edema factor (EF) and protective antigen (PA) in mice produces toxicity, and this protocol is commonly used to investigate the efficacy of specific antibodies in passive protection and vaccine studies. Availability of toxins labeled with imageable radioisotopes would allow to demonstrate their tissue distribution after intravenous injection at toxin concentration that are below pharmacologically significant to avoid masking by toxic effects. Methods: LF, EF and PA were radiolabeled with 188Re and 99mTc, and their performance in vitro was evaluated by macrophages and Chinese hamster ovary cells toxicity assays and by binding to macrophages. Scintigraphic imaging and biodistribution of intravenously (IV) injected 99mTc-and 123I-labeled toxins was performed in BALB/c mice. Results: Radiolabeled toxins preserved their biological activity. Scatchard-type analysis of the binding of radiolabeled PA to the J774.16 macrophage-like cells revealed 6.6×104 binding sites per cell with a dissociation constant of 6.7 nM. Comparative scintigraphic imaging of mice injected intravenously with either 99mTc-or 123I-labeled PA, EF and LF toxins demonstrated similar biodistribution patterns with early localization of radioactivity in the liver, spleen, intestines and excretion through kidneys. The finding of renal excretion shortly after IV injection strongly suggests that toxins are rapidly degraded which could contribute to the variability of mouse toxigenic assays. Biodistribution studies confirmed that all three toxins concentrated in the liver and the presence of high levels of radioactivity again implied rapid degradation in vivo. Conclusions: The availability of 188Re and 99mTc-labeled PA, LF and EF toxins allowed us to confirm the number of PA binding sites per cell, to provide an estimate of the dissociation constant of PA for its receptor and to demonstrate tissue distribution of toxins in mice after intravenous injection.
AB - Introduction: There is a lot of interest towards creating therapies and vaccines for Bacillus anthracis, a bacterium which causes anthrax in humans and which spores can be made into potent biological weapons. Systemic injection of lethal factor (LF), edema factor (EF) and protective antigen (PA) in mice produces toxicity, and this protocol is commonly used to investigate the efficacy of specific antibodies in passive protection and vaccine studies. Availability of toxins labeled with imageable radioisotopes would allow to demonstrate their tissue distribution after intravenous injection at toxin concentration that are below pharmacologically significant to avoid masking by toxic effects. Methods: LF, EF and PA were radiolabeled with 188Re and 99mTc, and their performance in vitro was evaluated by macrophages and Chinese hamster ovary cells toxicity assays and by binding to macrophages. Scintigraphic imaging and biodistribution of intravenously (IV) injected 99mTc-and 123I-labeled toxins was performed in BALB/c mice. Results: Radiolabeled toxins preserved their biological activity. Scatchard-type analysis of the binding of radiolabeled PA to the J774.16 macrophage-like cells revealed 6.6×104 binding sites per cell with a dissociation constant of 6.7 nM. Comparative scintigraphic imaging of mice injected intravenously with either 99mTc-or 123I-labeled PA, EF and LF toxins demonstrated similar biodistribution patterns with early localization of radioactivity in the liver, spleen, intestines and excretion through kidneys. The finding of renal excretion shortly after IV injection strongly suggests that toxins are rapidly degraded which could contribute to the variability of mouse toxigenic assays. Biodistribution studies confirmed that all three toxins concentrated in the liver and the presence of high levels of radioactivity again implied rapid degradation in vivo. Conclusions: The availability of 188Re and 99mTc-labeled PA, LF and EF toxins allowed us to confirm the number of PA binding sites per cell, to provide an estimate of the dissociation constant of PA for its receptor and to demonstrate tissue distribution of toxins in mice after intravenous injection.
KW - 188-Rhenium
KW - Anthrax
KW - Edema factor
KW - Lethal factor
KW - Protective antigen
KW - Scintigraphic imaging
UR - http://www.scopus.com/inward/record.url?scp=53249134529&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=53249134529&partnerID=8YFLogxK
U2 - 10.1016/j.nucmedbio.2008.07.001
DO - 10.1016/j.nucmedbio.2008.07.001
M3 - Article
C2 - 18848660
AN - SCOPUS:53249134529
SN - 0969-8051
VL - 35
SP - 755
EP - 761
JO - International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology
JF - International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology
IS - 7
ER -